|Bid||0.00 x 900|
|Ask||0.00 x 2900|
|Day's Range||10.11 - 10.52|
|52 Week Range||7.34 - 58.37|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||16.00|
New York, New York--(Newsfile Corp. - June 24, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Frequency Therapeutics, Inc. ("Frequency Therapeutics") (NASDAQ: FREQ) between November 16, 2020 and March 22, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of Massachusetts. To get more ...
NEW YORK, NY / ACCESSWIRE / June 24, 2021 / Pomerantz LLP announces that a class action lawsuit has been filed against Frequency Therapeutics, Inc. ("Frequency" or the "Company") (NASDAQ:FREQ) and certain of its officers.
NEW YORK, NY / ACCESSWIRE / June 24, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.